TARGETING WNT5A-MEDIATED THERAPY RESISTANCE MECHANISMS AND TUMOR GENOMIC HETEROGENEITY IN LETHAL BONE METASTATIC PROSTATE CANCER
$1,096,167FY2019Defense Health AgencyDOD
University Of California, San Diego, La Jolla CA
University Of California, San Diego, La Jolla CA